INKT – mink therapeutics, inc. (US:NASDAQ)
Stock Stats
News
MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy
MiNK Therapeutics (INKT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $35.00 price target on the stock.
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [TheStreet.com]
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference [Yahoo! Finance]
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
Form 10-K MiNK Therapeutics, Inc. For: Dec 31
Form 8-K MiNK Therapeutics, Inc. For: Mar 31
Form 8-K MiNK Therapeutics, Inc. For: Mar 27
Form 3 MiNK Therapeutics, Inc. For: Mar 13 Filed by: Charette Austin
Form 8-K MiNK Therapeutics, Inc. For: Mar 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.